CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vasamed, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vasamed, Inc.
7615 Golden Triangle Dr
Phone: (952) 944-5837p:952 944-5837 MINNEAPOLIS, MN  55344-3733  United States Ticker: VSMDVSMD

This company ceased filing statements with the SEC on 11/20/2006.

Business Summary
Vasamed Incorporated designs, licenses, manufactures and distributes products, software and services for assessing and managing hemodynamic health. The Company's SensiLase peripheral arterial disease (PAD)-IQ Studycast System provides measurement of tissue perfusion of the extremities particularly in patients with combined peripheral arterial disease and diabetes. The SensiLase PAD-IQ Studycast supports non-invasive upper and lower extremity vascular assessments, including skin perfusion pressure microcirculation (segmental pressure assessments with reactive hyperemia), pulse volume recording (segmental volume plethysmography) and ankle brachial index (ABI) calculation for doppler-obtained pressures; data sorting and customization options to support database mining, and wound imaging and surface area calculation featuring SmartDraw. SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals various support tools for both PAD and critical limb ischemia. On 9/5/2018, CHF Solutions, Inc. acquired the AcQtrac™ System technology from Vasamed, Inc.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200912/31/2008YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President and Chief Executive Officer and Director Paulita M.LaPlante 53 12/1/1998 1/1/1994
Chief Financial Officer, Vice President - Finance and Administration Roberta L.Dircks 66 6/21/2006 6/21/2006
Vice President - Operations Kent R.Winger 52 1/1/2006 1/1/2006
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Optical Sensors Incorporated
Optical Sensors, Inc.
VASAMED, Inc.
VSMD

General Information
Number of Employees: 31 (As of 12/31/2005)
Outstanding Shares: 8,011,457 (As of 6/30/2009)
Shareholders: 2,300
Stock Exchange: OTC
Federal Tax Id: 411643592
Fax Number: (952) 944-6022


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023